Patent Litigation

ALG is the market leader in patent litigation in Ireland, representing clients in the most significant patent infringement and invalidity actions before the Irish Commercial Court. We regularly collaborate with leading international law firms on Irish aspects of pan-European and US patent litigation.

Our integrated team combines legal and technical expertise to deliver comprehensive advice, excelling in tackling complex and technical work under tight deadlines. We advise clients on both day-to-day patent defensive and offensive strategies and pre-litigation matters, across various sectors including technology, life sciences, telecoms, and electronics, drawing on over 20 years’ experience in patent and SPC litigation.

We keep clients ahead of local and international patent law developments and have a stellar reputation for handling high-value cases, including licensing, R&D collaborations, and contractual disputes before the Irish High Court.

Our team’s technical qualifications and international experience enables us to develop and implement effective patent strategies tailored to Ireland and key global jurisdictions.

Our experience

  • Janssen v Amgen (SPC waiver).
  • Abbott Laboratories v Edwards Lifesciences (aortic valves).
  • Boston Scientific v Labcoat (commercialisation agreement breach).
  • Genentech v Amgen (SPC infringement anti-VEGF antibody).
  • Novartis AG v Actavis Group (Valsartan – hypertension drug).
  • GSK v Pfizer (MenB vaccine).
  • AstraZeneca v Pinewood Laboratories & Krka (Esomeprazole – proton pump inhibitor).
  • Infosint v Lundbeck & Forest Laboratories (Escitalopram – antidepressant).
  • Medinol v Abbott Laboratories (Coronary stents).
  • Fresenius Medical Care AG & Co KgaA v Baxter Healthcare S.A. (dialysis).
  • Ivax Pharmaceuticals v GSK (Seretide – asthma drug).
  • Teva v Amgen, Inc. (Neulasta (pegfilgrastim) - chemotherapy).
  • Teva v AstraZeneca (Symbicort – asthma drug).
  • Les Laboratoires Servier v Teva (Perindopril – blood pressure drug).
  • Medtronic v Abbott Laboratories & Guidant (Coronary stents).
  • Abbott Laboratories v Norton (Clarithromycin – anti- bacterial drug).
  • Pfizer v Ranbaxy (Lipitor – anti-cholesterol drug).
  • SmithKline Beecham v Genthon B.V. (Seroxat – antidepressant).

Key contacts


John Whelan

Partner, Technology

+353 1 649 2234

jwhelan@algoodbody.com

Read more>

Aideen Burke

Partner, Technology

+353 1 649 2627

aiburke@algoodbody.com

Read more>

Clare Carroll

Partner, Technology

+353 1 649 2586

cmcarroll@algoodbody.com

Read more>

Insights

Safeguarding Europe’s medicine supply – the Critical Medicines Act Mar 2025

View more insights >

Employment

Previous page

Disputes

Next page

©2025 A&L Goodbody LLP

All rights reserved

Privacy

Legal Notices

Cookie Policy

Manage cookies

Accessibility